We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

109 hedge funds and large institutions have $34.4M invested in Sanofi Contingent Value Rights in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 20 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more capital invested

Capital invested by funds: $13.5M → $34.4M (+$20.9M)

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

3% more funds holding

Funds holding: 106 → 109 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

50% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 20

Holders
109
Holders Change
+3
Holders Change %
+2.83%
% of All Funds
2.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
10
Reduced
20
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
+$3.48M
2
FCM
Farallon Capital Management
California
+$438K
3
BHMP
Bardin Hill Management Partners
New York
+$385K
4
ACM
Akanthos Capital Management
California
+$115K
5
PC
Permanens Capital
New York
+$19.4K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$61.8K
2
OAM
Oxford Asset Management
United Kingdom
-$43K
3
DAM
Deltec Asset Management
New York
-$42.6K
4
TI
Telemetry Investments
New York
-$23K
5
TL
TowerView LLC
New York
-$17.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teton Advisors
New York
$96K – – –
Goldman Sachs
27
Goldman Sachs
New York
$89K +$3.54K +20,608 +6%
BCM
28
Basso Capital Management
Connecticut
$66K -$16.3K -95,000 -26%
YCM
29
Yakira Capital Management
Connecticut
$37K – – –
First Eagle Investment Management
30
First Eagle Investment Management
New York
$35K – – –
Bank of America
31
Bank of America
North Carolina
$30K -$61.8K -359,278 -74%
EEG
32
E.E. Geduld
$30K – – –
UBS Group
33
UBS Group
Switzerland
$29K -$4.82K -28,022 -19%
PC
34
Permanens Capital
New York
$27K +$19.4K +112,982 New
PP
35
Paloma Partners
Connecticut
$24K – – –
IRF
36
IBM Retirement Fund
New York
$17K – – –
GI
37
GAMCO Investors
Connecticut
$16K – – –
JP Morgan Chase
38
JP Morgan Chase
New York
$15K -$258 -1,500 -2%
Citadel Advisors
39
Citadel Advisors
Florida
$15K +$10.4K +60,733 New
Wells Fargo
40
Wells Fargo
California
$14K -$244 -1,417 -2%
Korea Investment Corp
41
Korea Investment Corp
South Korea
$12K – – –
OCM
42
Osterweis Capital Management
California
$12K – – –
ZIG
43
Zuckerman Investment Group
Illinois
$11K – – –
Commonwealth Equity Services
44
Commonwealth Equity Services
Massachusetts
$10K -$12 -72 -0.2%
Morgan Stanley
45
Morgan Stanley
New York
$8K -$380 -2,208 -7%
CHAM
46
Clear Harbor Asset Management
Connecticut
$8K – – –
CI
47
Cowen Inc
New York
$8K +$5.73K +33,334 New
WHI
48
William Harris Investors
Illinois
$7K – – –
SDWMA
49
Schneider Downs Wealth Management Advisors
Pennsylvania
$6K – – –
PP
50
Pegasus Partners
Wisconsin
$5K – – –
1
2
3 4

GCVRZ Hedge Fund Activity: Q2 2016 in Review

109 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2016, worth a combined $34.4M — up 155% from $13.5M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new GCVRZ positions and 9 closed out — a net gain of 4 holders — while 10 added to existing stakes and 20 trimmed.

The largest buyer was TPG Group Holdings (SBS) Advisors, opening a new position worth an estimated $3.48M. The largest seller was Bank of America, cutting an estimated $61.8K.

  • 109 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2016, up from 106 in Q1 2016.
  • Funds reported $34.4M of Sanofi Contingent Value Rights stock for Q2 2016, up 155% quarter-over-quarter.
  • 13 funds opened new Sanofi Contingent Value Rights positions in Q2 2016 and 9 closed out, a net change of +4 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q2 2016 was TPG Group Holdings (SBS) Advisors, an estimated $3.48M added.
  • The largest Sanofi Contingent Value Rights seller in Q2 2016 was Bank of America, an estimated $61.8K sold.

Based on aggregated 13F filings for Q2 2016.